M. A. MIR, M.B., M.R.C.P.; B. BRABIN, M.B., Ch.B.; O. T. TANG, M.B., M.R.C.P.; M. J. LEYLAND, M.R.C.P.; I. W. DELAMORE, Ph.D., F.R.C.P.E.
Potassium balance studies were carried out in 32 consecutive patients with acute myeloid leukaemia and its variants. Serum K level fell below 3.5 meq/litre in 19 (59%) of these patients at some stage of their illness. There was no correlation between urinary and serum lysozyme (muramidase) concentrations and the low serum K level. In addition to the unexplained urinary K loss, there appear to be other factors contributing to the development of hypokalaemia.
M. A. MIR, B. BRABIN, O. T. TANG, M. J. LEYLAND, I. W. DELAMORE. Hypokalaemia in Acute Myeloid Leukaemia. Ann Intern Med. 1975;82:54–57. doi: 10.7326/0003-4819-82-1-54
Download citation file:
Published: Ann Intern Med. 1975;82(1):54-57.
Endocrine and Metabolism, Fluid and Electrolyte Disorders, Nephrology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use